TBI · Trueblue, Inc.

The thesis

TrueBlue's staffing recovery rests on PeopleReady, its blue-collar temporary-labor unit, and the third-quarter report decides whether revenue and gross margin match management's August outlook. The case breaks on a weekly close below $6.50. On 4 August 2026 TrueBlue reported second-quarter revenue of $443 million, up 12% year over year, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $11 million, against $3 million a year earlier. The same release showed a generally accepted accounting principles (GAAP) net loss of $3.4 million (TrueBlue Q2 2026 results).

The narrative is maturing: the 4 August 2026 report remains the latest company financial update, no company news or SEC filings have appeared since the 10 October 2026 note, and the shares closed at $8.82 on 22 October 2026, 18.7% below the 52-week high of $10.85. A search on 23 October 2026 found no company announcement of a third-quarter report date. TrueBlue announced its second-quarter date on 21 July 2026 for a 4 August 2026 release, and reported third-quarter 2025 results on 3 November 2025, so an early-November report is the working estimate. The rating stays where it was: nothing new about the business has arrived since the last note, and the close of $8.82 sits within five cents of the prior note's $8.87.

Bullish and bearish views on Trueblue, Inc.

The bull case on Trueblue, Inc. (TBI), in brief: PeopleReady drove the reported growth. The bear case: Gross margin missed its prior range.

Bull case

• PeopleReady drove the reported growth. TrueBlue's 4 August 2026 Q2 presentation put PeopleReady revenue at $262 million, up 23% year over year, with $9 million of segment profit. Management's Q3 outlook calls for 11%–15% PeopleReady growth; a result inside that range would extend the recovery.
• Adjusted operating earnings improved. The 4 August 2026 release reported adjusted EBITDA of $11 million against $3 million a year earlier. Q3 revenue inside management's $461–481 million outlook, with positive adjusted EBITDA, would confirm the improvement.
• An analyst raised its target after Q2. Baird raised its price target to $9.50 from $7 and kept an Outperform rating, dated 6 August 2026 by Investing.com and StockAnalysis. The $9.50 target sits above the $8.82 close of 22 October 2026.
• The shares have kept a three-month gain. Adjusted daily closes show a 13.1% three-month gain to the $8.82 close on 22 October 2026, with the 14-day relative strength index (RSI) at 42.3.

Bear case

• Gross margin missed its prior range. The 4 August 2026 Q2 presentation reported 20.7% gross margin, below the earlier 21.1%–21.5% management range. Management's Q3 outlook of 20.4%–20.8% implies no margin rebound; a result below 20.4% would weaken the operating-leverage case.
• Growth was uneven across segments. The 4 August 2026 presentation showed PeopleManagement revenue flat at $134 million and PeopleSolutions revenue down 5% at $47 million. The recovery so far rests on one segment.
• Profit is adjusted, not GAAP. The Q2 GAAP net loss was $3.4 million on 4 August 2026, and the Q1 2026 GAAP net loss was $19.8 million. GAAP profitability has not yet been reported.
• Liquidity is thin. At Q2 period-end TrueBlue reported $23 million of cash, $82 million of debt and $79 million of total liquidity after a $22 million working-capital increase. A later figure below $79 million would show further balance-sheet pressure.
• Few analysts cover the stock. Coverage was three firms (one Strong Buy, two Hold) on 11 August 2026, and published consensus figures differ widely by provider, so one new note can move the range.

Price setup

The adjusted daily close on 22 October 2026 was $8.82. That is 18.7% below the 52-week high of $10.85 and slightly under the $8.87 close of 9 October 2026. The 14-day RSI of 42.3 is a neutral-to-soft reading, with neither strong momentum nor oversold selling.

The $6.50 invalidation level sits well below the current price and under most of the move up from the $3.18 low. The stock's 60-month beta was 1.60 on 11 August 2026, so a single report or labor-market release can move it sharply in either direction.

Crowding evidence is limited. No insider transactions or share issuance appear in SEC filings since the last note, and no retail-attention data point is available. An earnings report is the one near-term event that could change the picture.

Catalysts, next 30 days

• ~6 November 2026 (est.): U.S. October Employment Situation report. Temporary-help employment gives a sector demand check but cannot resolve company-specific growth.

Elapsed catalysts

• ~3 November 2026 (est.): TrueBlue Q3 2026 results. The company has not confirmed the date. The report tests the 4 August 2026 outlook of $461–481 million revenue, 11%–15% PeopleReady growth and 20.4%–20.8% gross margin. (passed 3d ago)

What would change the view

The case breaks if the Q3 report shows PeopleReady growth below 11%, gross margin below 20.4% or an adjusted-EBITDA loss, because each would contradict the August outlook that the recovery rests on. A report that shows total liquidity below the Q2 figure of $79 million would add balance-sheet pressure. On price, a weekly close below $6.50 would erase most of the recovery from the $3.18 low.

A Q3 result inside the outlook, with PeopleManagement and PeopleSolutions stabilising, would strengthen the case and move the evidence toward a higher rating.

What it trades with

TrueBlue supplies temporary blue-collar labor, so its revenue follows U.S. industrial and construction hiring and the broader temporary-help market. The monthly Employment Situation report is the nearest public sector check. Some data providers tag the company as managed care; it is industrial staffing (PeopleReady, PeopleManagement, PeopleSolutions).